All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

58

Reset

58 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • KarX-ECBMS-986519, Xanomeline Enteric-coatedPhase 39 trials

    Bristol Myers Squibb · Alzheimer Disease, Alzheimer's Disease, Irritability Associated With Autism Spectrum Disorder

  • ObicetrapibPhase 37 trials

    NewAmsterdam Pharma · Lipidemia, Preclinical Alzheimer's Disease, Antioxidant Absorption

  • ITI-1284JNJ-99245354Phase 36 trials

    Intra-Cellular Therapies, Inc. · Generalized Anxiety Disorder, Agitation Associated With Alzheimer's Dementia, Psychotic Disorders

  • NPI-001N-Acetylcysteine AmidePhase 35 trials

    Nacuity Pharmaceuticals, Inc. · Retinitis Pigmentosa (RP), Usher Syndrome, Alzheimer´s Disease

  • ACP-204Phase 34 trials

    ACADIA Pharmaceuticals Inc. · Alzheimer's Disease Psychosis, Lewy Body Dementia Psychosis

  • TrontinemabRO7126209, RG6102Phase 34 trials

    Roche (Genentech) · Alzheimers Disease, Alzheimer's Disease

  • AXS-05dextromethorphan-bupropionPhase 33 trials

    Axsome Therapeutics, Inc. · Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Disease, Smoking Cessation

  • buntanetapposiphenPhase 33 trials

    Annovis Bio Inc. · Early Alzheimers Disease, Alzheimer's Dementia (AD), Parkinson's Disease (PD)

  • MasitinibAB1010Phase 33 trials

    AB Science · Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Alzheimer Disease

  • SPG302TazbentetolPhase 33 trials

    Spinogenix · Alzheimer Disease, Schizophrenia, Amyotrophic Lateral Sclerosis

  • TertomotideGV1001Phase 33 trials

    GemVax & Kael · Moderate to Severe Alzheimer's Disease, Mild to Moderate Alzheimer's Disease, Progressive Supranuclear Palsy

  • [18F]-APN-1607Phase 32 trials

    JYAMS PET Research & Development Limited · Alzheimer's Disease, Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia

  • ScandiBio Therapeutics AB · Alzheimer Disease, Gout Disease

  • DMB-IINN: Latrepirdine, DimebonPhase 32 trials

    Bigespas LTD · Alzheimer Type Dementia, Alzheimer Disease, Dementia of Alzheimer Type

  • SemagludtidePhase 32 trials

    Lumos Pharma · Obesity & Overweight, Early Alzheimer's Disease

  • AR1001Phase 31 trial

    AriBio Co., Ltd. · Alzheimer Disease

  • EXV-801deramciclanePhase 31 trial

    Exciva GmbH · Agitation Associated With Alzheimer's Disease Dementia

  • EXV-802Phase 31 trial

    Exciva GmbH · Agitation Associated With Alzheimer's Disease Dementia

  • Wanbangde Pharmaceutical Group Co., LTD · Alzheimer Dementia

  • MLC 901Phase 31 trial

    Moleac Pte Ltd. · Alzheimer's Disease Dementia

  • RemternetugLY3372993Phase 31 trial

    Eli Lilly · Alzheimer's Disease

  • SUVN-502MasupirdinePhase 31 trial

    Suven Life Sciences Limited · Agitation, Alzheimer's Type Dementia

  • XTR006[18F]MK 6240, FlorquinitauPhase 31 trial

    Sinotau Pharmaceutical Group · Alzheimer Disease, Neurofibrillary Tangle

  • ML-007C-MAPhase 24 trials

    MapLight Therapeutics · Psychosis Associated With Alzheimer's Disease, Schizophrenia

  • [18F]F-AraGPET tracer, 2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguaninePhase 22 trials

    CellSight Technologies, Inc. · Alzheimer Disease (AD), Covid19, SARS-CoV Infection

  • AMDX-2011PPhase 22 trials

    Amydis Inc. · Cerebral Amyloid Angiopathy, Alzheimer Disease

  • BMS-986368CC-97489Phase 22 trials

    Bristol Myers Squibb · Agitation, Alzheimer Disease, Multiple Sclerosis Spasticity

  • CT1812Study Drug ActivePhase 22 trials

    Cognition Therapeutics · Early Alzheimer's Disease, Dementia With Lewy Bodies

  • KDS2010Phase 22 trials

    NeuroBiogen Co., Ltd · Overweight, Obesity, Obese Patients

  • mivelsiranALN-APPPhase 22 trials

    Alnylam Pharmaceuticals · Cerebral Amyloid Angiopathy, Down Syndrome-Associated Alzheimer's Disease (DS-AD)

  • ONO-2020Phase 22 trials

    Ono Pharmaceutical Co., Ltd. · Agitation Associated With Alzheimer's Disease Dementia, Alzheimer Disease

  • RO7568282Phase 22 trials

    Roche (Genentech) · Parkinson's Disease, Alzheimer's Disease

  • SNK01Phase 22 trials

    NKGen Biotech, Inc. · Alzheimer Disease, Moderate Alzheimer Disease

  • VHB937Phase 22 trials

    Novartis · Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease

  • ABBV-1758Phase 21 trial

    AbbVie · Alzheimer's Disease

  • ABBV-916Phase 21 trial

    AbbVie · Alzheimer's Disease (AD)

  • ALZN002autologous DCs pulsed with E22W mutant peptidePhase 21 trial

    Alzamend Neuro, Inc. · Alzheimer Disease

  • BEY2153Phase 21 trial

    BeyondBio Inc. · Alzheimer Disease, Alzheimer' Disease

  • BMS-986446Phase 21 trial

    Bristol Myers Squibb · Alzheimer Disease, Early Onset

  • DiranersenISIS 814907, BIIB080Phase 21 trial

    Biogen · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia

  • E2814Phase 21 trial

    Eisai · Alzheimer's Disease

  • EI-1071Phase 21 trial

    Elixiron Immunotherapeutics Inc. · Mild, Moderate, or Severe Alzheimer's Disease

  • EX039Phase 21 trial

    Excelsior · Alzheimer Disease

  • GSK4527226Phase 21 trial

    GSK · Alzheimer's Disease

  • HT-4253Phase 21 trial

    Halia Therapeutics, Inc. · Alzheimers Disease

  • IVL3003Phase 21 trial

    Inventage Lab., Inc. · Alzheimer Disease

  • JNJ-64042056Phase 21 trial

    Johnson & Johnson (Janssen) · Alzheimer Disease

  • LHP588Phase 21 trial

    Lighthouse Pharmaceuticals, Inc. · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis

  • MK-2214Phase 21 trial

    Merck & Co. · Early Alzheimer's Disease

  • NBI-1117567Phase 21 trial

    Neurocrine Biosciences · Alzheimer's Disease

Page 1 of 2Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.